Literature DB >> 17113867

CHO glycosylation mutants: GPI anchor.

Yusuke Maeda1, Hisashi Ashida, Taroh Kinoshita.   

Abstract

Glycosylphosphatidylinositol (GPI) is used for anchoring many cell surface proteins to the plasma membrane. Biosynthesis of GPI anchor, its attachment to proteins, and modification of GPI-anchored proteins (GPI-APs) en route to the plasma membrane are complex processes (Ferguson, 1999; Kinoshita and Inoue, 2000). GPI-AP-defective mutant cell lines derived from CHO and other cells have been very useful in elucidating GPI biosynthetic pathway and cloning genes involved in these processes. In this chapter, we overview GPI-AP biosynthesis, establishment and characterization of GPI-AP-defective mutant cell lines, expression cloning using those mutant cells, and characteristics of GPI-AP-defective mutant cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113867     DOI: 10.1016/S0076-6879(06)16012-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  13 in total

1.  Glycosylphosphatidylinositol anchors regulate glycosphingolipid levels.

Authors:  Ursula Loizides-Mangold; Fabrice P A David; Victor J Nesatyy; Taroh Kinoshita; Howard Riezman
Journal:  J Lipid Res       Date:  2012-05-24       Impact factor: 5.922

2.  Glycosylphosphatidylinositol Anchor Modification Machinery Deficiency Is Responsible for the Formation of Pro-Prion Protein (PrP) in BxPC-3 Protein and Increases Cancer Cell Motility.

Authors:  Liheng Yang; Zhenxing Gao; Lipeng Hu; Guiru Wu; Xiaowen Yang; Lihua Zhang; Ying Zhu; Boon-Seng Wong; Wei Xin; Man-Sun Sy; Chaoyang Li
Journal:  J Biol Chem       Date:  2015-12-18       Impact factor: 5.157

3.  The fatal attraction between pro-prion and filamin A: prion as a marker in human cancers.

Authors:  Man-Sun Sy; Chaoyang Li; Shuiliang Yu; Wei Xin
Journal:  Biomark Med       Date:  2010-06       Impact factor: 2.851

4.  Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome.

Authors:  Yoshiko Murakami; Noriyuki Kanzawa; Kazunobu Saito; Peter M Krawitz; Stefan Mundlos; Peter N Robinson; Anastasios Karadimitris; Yusuke Maeda; Taroh Kinoshita
Journal:  J Biol Chem       Date:  2012-01-06       Impact factor: 5.157

Review 5.  Binding of pro-prion to filamin A: by design or an unfortunate blunder.

Authors:  C Li; W Xin; M-S Sy
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

6.  Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer.

Authors:  Chaoyang Li; Shuiliang Yu; Fumihiko Nakamura; Shaoman Yin; Jinghua Xu; Amber A Petrolla; Neena Singh; Alan Tartakoff; Derek W Abbott; Wei Xin; Man-Sun Sy
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

Review 7.  Glycoconjugate glycosyltransferases.

Authors:  Koichi Furukawa; Akiko Tsuchida; Tetsuya Okajima; Keiko Furukawa
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

Review 8.  Human genetic disorders involving glycosylphosphatidylinositol (GPI) anchors and glycosphingolipids (GSL).

Authors:  Bobby G Ng; Hudson H Freeze
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

Review 9.  Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling.

Authors:  Taroh Kinoshita; Morihisa Fujita
Journal:  J Lipid Res       Date:  2015-11-12       Impact factor: 5.922

10.  Detection of PIGO-deficient cells using proaerolysin: a valuable tool to investigate mechanisms of mutagenesis in the DT40 cell system.

Authors:  Jun Nakamura; Husamettin Gul; Xu Tian; Scott J Bultman; James A Swenberg
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.